辅助生殖技术临床风险核心指标的监测与管理
Monitoring and management of core clinical risk indicators for assisted reproductive technology
梅洁 1孙海翔1
作者信息
- 1. 南京大学医学院附属鼓楼医院生殖医学和妇产医学中心 南京大学分子生殖医学中心,南京 210008
- 折叠
摘要
辅助生殖技术(assisted reproductive technology,ART)是解决不孕不育患者生育问题的重要手段.欧洲人类生殖和胚胎学协会将ART治疗成功的标准定义为无卵巢过度刺激综合征获得单胎妊娠和足月健康婴儿,因此卵巢过度刺激率和多胎妊娠率是ART临床风险核心指标.加强ART临床风险核心指标的监测评估,构建高危人群风险预防与策略优化的闭环体系,可以明显减少不孕症女性ART相关的医源性并发症,促进ART的良性、有序发展,更好地满足群众生殖健康服务需求.
Abstract
Assisted reproductive technology(ART)is the means to solve the fertility problem of infertile patients.The European Society of Human Reproduction and Embryology defines the success criteria for ART treatment as"single pregnancy and full-term healthy infants without ovarian hyperstimulation syndrome".Therefore,ovarian hyperstimulation rate and multiple pregnancy rate are core clinical risk indicators for ART.We should strengthen the monitoring of clinical risk indicators for ART,and construct a closed-loop system for risk prevention and strategy optimization for high-risk populations.It will reduce the iatrogenic complications related to ART in infertile women,and promote the orderly development of ART.
关键词
生殖技术,辅助/卵巢过度刺激综合征/多胎妊娠Key words
Reproductive techniques,assisted/Ovarian hyperstimulation syndrome/Multiple pregnancy引用本文复制引用
出版年
2024
NETL
NSTL
万方数据